Antibodies after Botulinum Toxin A Injection into Musculus Detrusor Vesicae: Incidence and Clinical Relevance

Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome

(2010) Hann-Chorng Kuo et al.   EUROPEAN UROLOGY

Emerging drugs for treatment of urinary incontinence

(2010) Monika Vij et al.   EXPERT OPINION ON EMERGING DRUGS

Outcomes of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder Symptoms: A Systematic Review of the Literature

(2010) Jennifer T. Anger et al.   JOURNAL OF UROLOGY

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

(2010) Daniel Truong et al.   PARKINSONISM & RELATED DISORDERS

Wirkung von Botulinumtoxin A in der ein- und mehrmaligen Behandlung der überaktiven Blase

(2010) C. Frohme et al.   UROLOGE

Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review

(2010) Randall K. Leong et al.   UROLOGIA INTERNATIONALIS

Antibody Formation Following Botulinum Toxin Type A (Dysport) Injection in Children With Intractable Bladder Hyper-reflexia

(2010) Abdol-Mohammad Kajbafzadeh et al.   UROLOGY

Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A

(2009) Oliver Lange et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence

(2009) Karl-Erik Andersson et al.   CURRENT OPINION IN UROLOGY

Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity

(2009) Kerstin Müller et al.   JOURNAL OF NEURAL TRANSMISSION

Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years

(2009) Manfred Stoehrer et al.   UROLOGIA INTERNATIONALIS

Repeated Injections of Botulinum Toxin-A for Idiopathic Detrusor Overactivity

(2009) Arun Sahai et al.   UROLOGY

Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity

(2008) D.M. Schmid et al.   BJU INTERNATIONAL

Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report

(2008) Apostolos Apostolidis et al.   EUROPEAN UROLOGY

Botulinum neurotoxin type A in urology: Antibodies as a cause of therapy failure

(2008) Heinrich Schulte-Baukloh et al.   INTERNATIONAL JOURNAL OF UROLOGY

Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up

(2008) Stefanie Kuschel et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

(2008) Mitchell F. Brin et al.   MOVEMENT DISORDERS